Connecticut SB 262: AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.

Status: HOUSE CALENDAR NUMBER 554 (as of 2021-05-27)

State: Connecticut · Session: 2021 · Bill: SB 262

Subjects: Drug manufacturers, Drug wholesalers, Pharmaceutical industry, Unfair or deceptive trade practices

Sponsors: Looney, Martin M.

View Connecticut SB 262 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.